Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis

References

• Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1(1):1–18.
   Web of Science ®Google Scholar
• Oxman MN. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence. Journal of Osteopathic Medicine. 2009;109(s62):13–17.
   Google Scholar
• Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. SAGE Publications; 1965.
   Google Scholar
• Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clinl Infect Dis. 2007;44(Supplement_1):S1–S26.
   PubMedGoogle Scholar
• Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014 Jun 10;4(6):e004833.
   PubMed Web of Science ®Google Scholar
• Kawai K, Yawn BP. Risk Factors for Herpes Zoster: a Systematic Review and Meta-analysis. Mayo Clin Proc. 2017 Dec;92(12):1806–1821.
   PubMed Web of Science ®Google Scholar
• Price NB, and Grose C. Corticosteroids Contribute to Serious Adverse Events Following Live Attenuated Varicella Vaccination and Live Attenuated Zoster Vaccination. Vaccines (Basel). 2021;9(1):23.
   PubMed Web of Science ®Google Scholar
• van Dam CS, Lede I, Schaar J, et al. Herpes zoster after COVID vaccination. Int J Infect Dis. 2021;111:169–171.
   PubMed Web of Science ®Google Scholar
• Al-Amer R, Maneze D, Everett B, et al. COVID-19 vaccination intention in the first year of the pandemic: a systematic review. J Clin Nurs. 2022 Jan;31(1–2):62–86.
   PubMed Web of Science ®Google Scholar
• Costa SF, Carranza SV, Giavina-Bianchi P, et al. Adherence to non-pharmacological preventive measures among healthcare workers in a middle-income country during the first year of the COVID-19 pandemic: hospital and community setting. Am J Infect Control. 2021 Dec 24. DOI:https://doi.org/10.1016/j.ajic.2021.12.004.
   Google Scholar
• Ling Y, Zhong J, Luo J. Safety and effectiveness of SARS-CoV-2 vaccines: a systematic review and meta-analysis. J Med Virol. 2021 Dec;93(12):6486–6495.
   PubMed Web of Science ®Google Scholar
• Pormohammad A, Zarei M, Ghorbani S, et al. Efficacy and Safety of COVID-19 Vaccines: a Systematic Review and Meta-Analysis of Randomized Clinical Trials. Vaccines (Basel). 2021 May 6;9(5). DOI:https://doi.org/10.3390/vaccines9050467.
   Google Scholar
• Cheng H, Peng Z, Luo W, et al. Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: a Meta-Analysis. Vaccines (Basel). 2021 Jun 1;9(6). DOI:https://doi.org/10.3390/vaccines9060582.
   Google Scholar
• Mulligan MJ, Lyke KE, and Kitchin N, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020 Oct;586(7830):589–593.
   PubMed Web of Science ®Google Scholar
• Brosh-Nissimov T, Sorek N, Yeshayahu M, et al. Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19. Vaccine. 2021 Sep 24;39(40):5729–5731.
   PubMed Web of Science ®Google Scholar
• Shasha D, Bareket R, Sikron FH, et al. Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study. Clin Microbiol Infect. 2022 Jan;28(1):130–134.
   PubMed Web of Science ®Google Scholar
• Kluger N, Klimenko T, Bosonnet S. Herpes simplex, herpes zoster and periorbital erythema flares after SARS-CoV-2 vaccination: 4 cases. Ann Dermatol Venereol. 2021 Oct 2. DOI:https://doi.org/10.1016/j.annder.2021.07.009.
   Google Scholar
• Rodriguez-Jimenez P, Chicharro P, Cabrera LM, et al. Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: report of 5 cases. JAAD Case Rep. 2021 Jun;12:58–59.
   PubMedGoogle Scholar
• Chi CC, Chen TH, Wang SH, et al. Risk of Suicidality in People with Psoriasis: a Systematic Review and Meta-Analysis of Cohort Studies. Am J Clin Dermatol. 2017 Oct;18(5):621–627.
   PubMed Web of Science ®Google Scholar
• Peterson J, Welch V, and Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. 2011;1–2.
   Google Scholar
• Higgins JP, Thompson, SG, Deeks, JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003 Sep 6;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med. 2021 Sep 16;385(12):1078–1090.
   PubMed Web of Science ®Google Scholar
• Birabaharan M, Kaelber DC, Karris MY. Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: a cohort study. J Am Acad Dermatol. 2021 Nov 23. DOI:https://doi.org/10.1016/j.jaad.2021.11.025.
   Google Scholar
• McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021 Jul;85(1):46–55.
   PubMed Web of Science ®Google Scholar
• Koshy E, Mengting L, Kumar H, et al. Epidemiology, treatment and prevention of herpes zoster: a comprehensive review. Indian J Dermatol Venereol Leprol. 2018 May-Jun;84(3):251–262.
   PubMed Web of Science ®Google Scholar
• Weinberg JM. Herpes zoster: epidemiology, natural history, and common complications. J Am Acad Dermatol. 2007 Dec;57(6 Suppl):S130–5.
   PubMed Web of Science ®Google Scholar
• Mareque M, Oyagüez I, Morano R, et al. Systematic review of the evidence on the epidemiology of herpes zoster: incidence in the general population and specific subpopulations in Spain. Public Health. 2019 2019/02/01/;167:136–146.
   PubMed Web of Science ®Google Scholar
• Fernandes N. Economic effects of coronavirus outbreak (COVID-19) on the world economy. Available at SSRN 3557504. 2020.
   Google Scholar
• Haleem A, Javaid M, Vaishya R. Effects of COVID-19 pandemic in daily life. Curr Med Res Pract. 2020 Mar-Apr;10(2):78–79.
   PubMedGoogle Scholar
• Fan H, Tang X, Song Y, et al. Influence of COVID-19 on Cerebrovascular Disease and its Possible Mechanism. Neuropsychiatr Dis Treat. 2020;16:1359–1367.
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034.
   PubMed Web of Science ®Google Scholar
• Schaffer Deroo S, Pudalov NJ, Fu LY. Planning for a COVID-19 Vaccination Program. JAMA. 2020 Jun 23;323(24):2458–2459.
   PubMed Web of Science ®Google Scholar
• Klugar M, Riad A, Mekhemar M, et al. Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers. Biology (Basel). 2021 Aug 5;10(8). DOI:https://doi.org/10.3390/biology10080752.
   Google Scholar
• Saeed BQ, Al-Shahrabi R, Alhaj SS, et al. Side effects and perceptions following Sinopharm COVID-19 vaccination. Int J Infect Dis. 2021 Oct;111:219–226.
   PubMed Web of Science ®Google Scholar
• Walach H, Klement RJ, Aukema W. The Safety of COVID-19 Vaccinations—We Should Rethink the Policy. Vaccines (Basel). 2021;9(7):693.
   PubMed Web of Science ®Google Scholar
• Thompson MG, Stenehjem E, Grannis S, et al. Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings. N Engl J Med. 2021;385(15):1355–1371.
   PubMed Web of Science ®Google Scholar
• Moline HL, Whitaker M, Deng L, et al. Effectiveness of COVID-19 vaccines in preventing hospitalization among adults aged≥ 65 years—COVID-NET, 13 states, February–April 2021. Morbidity Mortality Weekly Rep. 2021;70(32):1088.
   PubMed Web of Science ®Google Scholar
• Tenforde MW, Self WH, Adams K, et al. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. Jama. 2021;326(20):2043–2054.
   PubMed Web of Science ®Google Scholar
• Elsaie ML, Youssef EA, Nada HA. Herpes zoster might be an indicator for latent COVID 19 infection. Dermatol Ther. 2020 Jul;33(4):e13666.
   PubMed Web of Science ®Google Scholar
• Wollina U, Chiriac A, Kocic H, et al. Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination-a narrative review. Wien Med Wochenschr. 2021 Aug 23. DOI:https://doi.org/10.1007/s10354-021-00876-0.
   Google Scholar
• Ayatollahi A, Robati RM, Firooz A. Plantar herpes zoster following heterologous recombinant adenovirus-based COVID-19 vaccine. J Cosmet Dermatol. 2022 Jan;21(1):34–35.
   PubMed Web of Science ®Google Scholar
• Gambichler T, Boms S, and Susok L, et al. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol. 2022;36(2): 172–80.
   PubMed Web of Science ®Google Scholar
• Shah S, Baral B, Chamlagain R, et al. Reactivation of herpes zoster after vaccination with an inactivated vaccine: a case report from Nepal. Clin Case Rep. 2021 Dec;9(12):e05188.
   PubMed Web of Science ®Google Scholar
• Folegatti PM, Ewer KJ, Aley PK, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396(10249):467–478.
   PubMed Web of Science ®Google Scholar
• Iwanaga J, Fukuoka H, Fukuoka N, et al. A narrative review and clinical anatomy of herpes zoster infection following COVID‐19 vaccination. Clin Anat. 2021;35(1):45–51.
   PubMed Web of Science ®Google Scholar
• Fathy RA, McMahon DE, Lee C, et al. Varicella‐zoster and herpes simplex virus reactivation post‐COVID‐19 vaccination: a review of 40 cases in an International Dermatology Registry. J Eur Acad Dermatol Venereol. 2021;36(1):e6–e9.
   PubMed Web of Science ®Google Scholar
• Wollina U, Karadag AS, Rowland-Payne C, et al. Cutaneous signs in COVID-19 patients: a review. Dermatol Ther. 2020 Sep;33(5):e13549.
   PubMed Web of Science ®Google Scholar
• Sedgwick P. Meta-analyses: what is heterogeneity? Bmj. 2015;350.
   Google Scholar
• Bellou V, Belbasis L, Tzoulaki I, et al. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses. PLoS One. 2018;13(3):e0194127.
   PubMed Web of Science ®Google Scholar